Results & timelines
The GLP-1 weight loss plateau
October 2, 2026 · 6 min read · Medically reviewed by Bryan Milton, MD · Reviewed October 2, 2026
Progress slowing is expected rather than a malfunction. What drives a plateau, what is worth changing, and what your clinician can do about it.
Almost everyone reaches a point where progress slows, and almost everyone experiences it as something going wrong. Mostly it is not. A plateau has a straightforward explanation, and the useful responses are not the obvious ones.
Why does progress slow?
Energy use scales with body size. A smaller body requires less energy to maintain, so an intake that produced a deficit at the start produces a smaller one later — eventually none. That happens regardless of what caused the weight loss, and it is the main reason loss is faster early and slower later.
Two things make it steeper:
- Lean mass loss. Muscle is metabolically active; losing a lot of it lowers resting energy use more than the weight change alone would suggest.
- Intake drifting up without being noticed. As side effects settle and appetite partially returns, portions grow back gradually. This is normal and nearly invisible without some form of tracking.
Is it a plateau or a pause?
Worth distinguishing, because they need different responses. Weight fluctuates by a couple of pounds day to day from fluid, food timing, hormones and bowel habit. Two flat weeks is probably noise. Four to six weeks genuinely flat, on a stable dose, is a plateau worth discussing.
| Likely noise | Likely a plateau | |
|---|---|---|
| Duration | Days to two weeks | Four to six weeks or more |
| Dose | Recently changed | Stable for a while |
| Trend | Flat but still drifting down | Genuinely flat or rising |
| Other signals | Clothes still changing | Nothing changing at all |
What actually helps
- Protein and resistance training. If you take one thing from this article: a plateau is the moment the lean mass question becomes concrete, and training is the lever.
- An honest look at intake. Not a crackdown — a look. Portions creep back as appetite returns, and noticing is most of the fix.
- Sleep, which affects appetite regulation more than people credit.
- Patience with the number. Body composition can be changing while the scale is not, particularly if you have started training.
- A conversation with your clinician, who may adjust the dose. A plateau is one of the recognised reasons to review it.
What does not help
Cutting intake much further is the instinct and usually the wrong move: it accelerates lean mass loss, worsens fatigue, and makes the next stage harder. Increasing your own dose is an unmonitored dose change. Daily weighing during a plateau mostly produces distress. And treating a plateau as proof the medication has failed is premature — it is a predictable stage, not a malfunction.
What if the plateau is the end point?
It might be, and that is not a failure either. Treatment aims at what is appropriate for you rather than at a number from somewhere else, and a plateau that your clinician considers a reasonable place to be is a result rather than a stall. That is a conversation worth having explicitly, because an unspoken expectation is what turns a reasonable outcome into a disappointment.
GLP does not publish expected results. The figures in circulation come from trials of the FDA-approved products on their approved schedules, averaged across thousands of participants — they do not describe a compounded preparation, a lower dose, or you. A service that tells you what you will achieve is telling you something it cannot know.
This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.